CY1790A - Purification of recombinant hepatitis B surface antigen - Google Patents
Purification of recombinant hepatitis B surface antigenInfo
- Publication number
- CY1790A CY1790A CY179095A CY179095A CY1790A CY 1790 A CY1790 A CY 1790A CY 179095 A CY179095 A CY 179095A CY 179095 A CY179095 A CY 179095A CY 1790 A CY1790 A CY 1790A
- Authority
- CY
- Cyprus
- Prior art keywords
- antigen
- purification
- surface antigen
- yeast
- daltons
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2334787A | 1987-03-09 | 1987-03-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1790A true CY1790A (en) | 1995-10-20 |
Family
ID=21814559
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY179095A CY1790A (en) | 1987-03-09 | 1995-10-20 | Purification of recombinant hepatitis B surface antigen |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0291146B1 (de) |
| JP (1) | JPS63270629A (de) |
| AT (1) | ATE93891T1 (de) |
| AU (1) | AU608813B2 (de) |
| CA (1) | CA1304887C (de) |
| CY (1) | CY1790A (de) |
| DE (1) | DE3883596T2 (de) |
| DK (1) | DK123288A (de) |
| ES (1) | ES2043808T3 (de) |
| HK (1) | HK48094A (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR960023066A (ko) * | 1994-12-10 | 1996-07-18 | 성재갑 | 전에스 (s) 2 펩티드 함유 비 (b) 형 간염 표면항원의 정제 방법 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU584580B2 (en) * | 1982-09-08 | 1989-06-01 | Smith Kline - Rit | Hepatitis B virus vaccine |
| EP0401941A3 (de) * | 1984-07-11 | 1991-04-17 | Takeda Chemical Industries, Ltd. | Hepatitis B-Virus-Oberflächen-Antigen und seine Herstellung |
| US4895800A (en) * | 1985-11-26 | 1990-01-23 | Phillips Petroleum Company | Yeast production of hepatitis B surface antigen |
| JPS62298536A (ja) * | 1986-06-17 | 1987-12-25 | Green Cross Corp:The | 生理活性物質の自動精製方法および自動精製装置 |
| ATE91304T1 (de) * | 1987-02-27 | 1993-07-15 | Merck & Co Inc | Verfahren zur herstellung des pres 1/s2/shepatitis-b-antigens aus hefe. |
-
1988
- 1988-03-01 EP EP88301779A patent/EP0291146B1/de not_active Expired - Lifetime
- 1988-03-01 ES ES88301779T patent/ES2043808T3/es not_active Expired - Lifetime
- 1988-03-01 AT AT88301779T patent/ATE93891T1/de active
- 1988-03-01 DE DE88301779T patent/DE3883596T2/de not_active Expired - Fee Related
- 1988-03-08 CA CA000560864A patent/CA1304887C/en not_active Expired - Fee Related
- 1988-03-08 DK DK123288A patent/DK123288A/da not_active Application Discontinuation
- 1988-03-08 AU AU12778/88A patent/AU608813B2/en not_active Ceased
- 1988-03-09 JP JP63055919A patent/JPS63270629A/ja active Pending
-
1994
- 1994-05-12 HK HK48094A patent/HK48094A/xx unknown
-
1995
- 1995-10-20 CY CY179095A patent/CY1790A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK123288D0 (da) | 1988-03-08 |
| DK123288A (da) | 1988-09-10 |
| HK48094A (en) | 1994-05-20 |
| ES2043808T3 (es) | 1994-01-01 |
| CA1304887C (en) | 1992-07-07 |
| ATE93891T1 (de) | 1993-09-15 |
| EP0291146A2 (de) | 1988-11-17 |
| JPS63270629A (ja) | 1988-11-08 |
| EP0291146B1 (de) | 1993-09-01 |
| DE3883596T2 (de) | 1994-02-17 |
| AU608813B2 (en) | 1991-04-18 |
| EP0291146A3 (en) | 1989-12-06 |
| DE3883596D1 (de) | 1993-10-07 |
| AU1277888A (en) | 1988-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69332334T2 (de) | Verfahren zur verstärkten expression von virusproteinen | |
| ATE187775T1 (de) | Verfahren zur herstellung von menschlichem serumalbumin in hefe | |
| CA2020668A1 (en) | Fused or hybrid protein comprising viral antigen and lymphokine | |
| FI101381B1 (fi) | Nukleotidisekvenssi ja menetelmä polypeptidin HSA(1-387) tuottamiseksi | |
| ATE373010T1 (de) | Gag-antigen und dessen verwendung zum nachweis von lav-infektion, sowie in immunogenen zusammensetzungen | |
| ATE173275T1 (de) | Von einem retrovirus aus der hiv-gruppe abgeleitete peptide und deren verwendung | |
| IL90035A (en) | Synthetic multimeric hepatitis b virus vaccine including both t cell and b cell determinants | |
| FI19992546A (fi) | Hepatiitti B:n S- ja PreS2-proteiinien ilmentäminen metylotrofisissa hiivoissa | |
| EP0423224A4 (en) | Leader sequence inducing a post-translational modification of polypeptides in bacteria, and gene therefor | |
| ATE6402T1 (de) | Verfahren zur herstellung von hepatitis b oberflaechenantigen. | |
| GR3007031T3 (de) | ||
| HK48094A (en) | Purification of recombinant hepatitis B surface antigen | |
| IL88377A0 (en) | Molecular cloning of the human interferon type 1 receptor | |
| DE3750348D1 (de) | Verfahren zur Herstellung von Peptiden, dazu zu verwendendes rekombinantes Plasmid und mit diesem Plasmid transformierte Myelomzellen. | |
| ES2078229T3 (es) | Procedimiento para la preparacion de un polipeptido similar a la motilina y su expresion. | |
| EP0433378A4 (en) | Allelic variants of -i(plasmodium falciparum) merozoite surface antigen | |
| NZ230996A (en) | Immunogenic recombinant polypeptides and their use in the production of neutralising antibodies against viral haemorrhagic septicaemia virus | |
| PT89041A (pt) | Metodo de preparacao de diagnosticos e vacinas nanbv | |
| SU1380209A1 (ru) | РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК PUR 291-HAV 22, КОДИРУЮЩАЯ СИНТЕЗ ГИБРИДНОГО ПОЛИПЕПТИДА АНТИГЕННЫХ ДЕТЕРМИНАНТ ВИРУСА ГЕПАТИТА А С β -ГАЛАКТОЗИДАЗОЙ |